WORK Medical Technology Group LTD Ordinary Shares (WOK) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
WORK Medical Technology Group LTD Ordinary Shares stock (WOK) is currently trading at $1.21. WORK Medical Technology Group LTD Ordinary Shares PS ratio (Price-to-Sales) is 0.15. WallStSmart rates WOK as Sell.
- WOK PE ratio analysis and historical PE chart
- WOK PS ratio (Price-to-Sales) history and trend
- WOK intrinsic value — DCF, Graham Number, EPV models
- WOK stock price prediction 2025 2026 2027 2028 2029 2030
- WOK fair value vs current price
- WOK insider transactions and insider buying
- Is WOK undervalued or overvalued?
- WORK Medical Technology Group LTD Ordinary Shares financial analysis — revenue, earnings, cash flow
- WOK Piotroski F-Score and Altman Z-Score
- WOK analyst price target and Smart Rating
WORK Medical Technology Group
📊 No data available
Try selecting a different time range
Smart Analysis
WORK Medical Technology Group LTD Ordinary Shares (WOK) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
WORK Medical Technology Group LTD Ordinary Shares (WOK) Key Strengths (2)
Paying less than $1 for every $1 of annual revenue
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
WORK Medical Technology Group LTD Ordinary Shares (WOK) Areas to Watch (7)
Company is destroying shareholder value
Losing money on operations
Revenue declining -14.40%, a shrinking business
Earnings declining -95.00%, profits shrinking
Company is losing money with a negative profit margin
Very low institutional interest at 0.16%
Micro-cap company with very limited liquidity and high volatility
WORK Medical Technology Group LTD Ordinary Shares (WOK) Detailed Analysis Report
Overall Assessment
This company scores 29/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 2 register as strengths (avg 10.0/10) while 7 fall into concern territory (avg 0.7/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.15), Price/Book (0.08) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -14.40%, EPS Growth at -95.00%, which may limit upside. Profitability pressure is visible in Return on Equity at -6.45%, Operating Margin at -17.50%, Profit Margin at -10.90%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -6.45% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -14.40% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
WOK Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
WOK's Price-to-Sales ratio of 0.15x trades 17% below its historical average of 0.18x (50th percentile). The current valuation is 70% below its historical high of 0.49x set in Nov 2025, and Infinity% above its historical low of 0x in Dec 2025. Over the past 12 months, the PS ratio has expanded from ~0.0x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for WORK Medical Technology Group LTD Ordinary Shares (WOK) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
WORK Medical Technology Group LTD Ordinary Shares is in a turnaround phase, with management focused on restoring profitability. Revenue reached 10M with 14% decline year-over-year. The company is currently unprofitable, posting a -10.9% profit margin.
Key Findings
Generating 8M in free cash flow and 9M in operating cash flow. Earnings are translating into actual cash generation.
Revenue contracted 14% YoY. Worth determining whether this is cyclical or structural.
The company is unprofitable with a -10.9% profit margin. The path to breakeven will be the key catalyst.
What to Watch Next
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact WORK Medical Technology Group LTD Ordinary Shares.
Bottom Line
WORK Medical Technology Group LTD Ordinary Shares is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 12:57:02 PM
About WORK Medical Technology Group LTD Ordinary Shares(WOK)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
WORK Medical Technology Group Ltd is a prominent player in the medical technology sector, specializing in the research, development, and commercialization of innovative healthcare solutions. The company focuses on creating advanced medical devices that significantly improve patient outcomes and meet pressing global healthcare challenges. With a strong dedication to quality and a diverse product portfolio, WORK is strategically positioned for sustained growth, making it an appealing investment choice for institutional investors aiming to capitalize on transformative developments in the healthcare industry.